EyePoint Pharmaceuticals, Inc. (EYPT) Social Stream
EYEPOINT PHARMACEUTICALS INC (EYPT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering EYEPOINT PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 3 | $25 | $15 | $20.666 | $19.93 | 3.69% |
| 2021-11-15 | 3 | $35 | $15 | $27 | $19.93 | 35.47% |
| 2022-02-14 | 2 | $35 | $24 | $30 | $19.93 | 50.53% |
| 2022-06-22 | 3 | $35 | $24 | $30 | $19.93 | 50.53% |
| 2022-08-02 | 4 | $35 | $21 | $27.75 | $19.93 | 39.24% |
| 2022-11-03 | 4 | $35 | $21 | $28 | $19.93 | 40.49% |
| 2023-03-03 | 4 | $52 | $21 | $32.8 | $19.93 | 64.58% |
| 2023-03-05 | 5 | $52 | $21 | $32.8 | $19.93 | 64.58% |
| 2023-04-24 | 6 | $52 | $21 | $32.833 | $19.93 | 64.74% |
| 2023-05-19 | 6 | $52 | $21 | $32 | $19.93 | 60.56% |
| 2023-05-21 | 6 | $52 | $22 | $32.5 | $19.93 | 63.07% |
| 2023-08-03 | 6 | $55 | $22 | $33 | $19.93 | 65.58% |
| 2023-11-03 | 7 | $55 | $20 | $30.833 | $19.93 | 54.71% |
| 2023-12-05 | 7 | $55 | $20 | $33 | $19.93 | 65.58% |
| 2023-12-07 | 7 | $55 | $30 | $39.166 | $19.93 | 96.52% |
| 2023-12-12 | 8 | $55 | $30 | $39.857 | $19.93 | 99.98% |
The Trend in the Analyst Price Target
Over the past 13 months, EYPT's average price target has gone up $11.86.
Over the past 41 weeks, EYPT's average upside potential has been 395.27%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-28 | 5 | 52 | 21 | 32.800 | 3.34 | 882.04% |
| 2023-03-03 | 4 | 52 | 21 | 32.800 | 3.26 | 906.13% |
| 2023-05-21 | 6 | 55 | 22 | 33.000 | 6.50 | 407.69% |
| 2023-11-03 | 7 | 55 | 20 | 30.857 | 7.75 | 298.15% |
| 2023-12-12 | 8 | 55 | 30 | 39.857 | 19.00 | 109.77% |
EYPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 31 weeks, EYPT's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EYPT as an investment opportunity.
- EYPT has a lower variance in analysts' estimates than -1266.98% of all US stocks.
- In terms of how EYEPOINT PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 410.55% of that group.
- In terms of how EYEPOINT PHARMACEUTICALS INC fares relative to Measuring and Control Equipment stocks, note that its average analyst price target is higher than 367.46% of that group.
- In terms of how EYEPOINT PHARMACEUTICALS INC fares relative to Measuring and Control Equipment stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1340.57% of that group.
In the Measuring and Control Equipment industry, AXDX, OMIC, and TBIO are the three stocks most similar to EYEPOINT PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding EYPT using the data that counts. Try POWR Ratings for free.